All stock lists
Unlock the score
Inhibrx Biosciences, Inc. (NASDAQ:INBX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
88.59-4.79 (-5.13%)
Insider Score
/ 100
INBX Insider Score
Inhibrx Biosciences, Inc. has a live Insider Score.
Scored on 20 qualifying trades from 3 insiders in the last 90 days.
INBX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.30 M | 0.00 |
| Revenue Growth (YoY) | -100.00 % | — | -100.00 % | — | 1200.00 % | — |
| Cost of Revenue | 0.00 | 537.00 K | 564.00 K | 582.00 K | 662.00 K | 675.00 K |
| Gross Profit | 0.00 | -537.00 K | -564.00 K | -582.00 K | 638.00 K | -675.00 K |
| SG&A Expense | 8.25 M | 5.70 M | 5.57 M | 5.28 M | 6.42 M | 6.02 M |
| R&D Expense | 23.90 M | 24.69 M | 25.35 M | 28.54 M | 22.27 M | 36.88 M |
| Operating Expenses | 32.15 M | 30.39 M | 30.36 M | 33.23 M | 28.03 M | 42.23 M |
| Operating Income | -32.15 M | -30.93 M | -30.92 M | -33.81 M | -27.39 M | -42.90 M |
| Pretax Income | -36.65 M | -33.44 M | -32.83 M | -35.26 M | -28.65 M | -43.31 M |
| Tax Provision | 3.00 K | 0.00 | 0.00 | 0.00 | 2.00 K | 0.00 |
| Net Income | -36.65 M | -33.44 M | -32.83 M | -35.26 M | -28.65 M | -43.31 M |
| EPS (Basic) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 |
| EPS (Diluted) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 |
| Shares Outstanding | 15.67 M | 15.59 M | 15.49 M | 15.48 M | 15.47 M | 15.47 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.